We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vindon H. | LSE:VDN | London | Ordinary Share | GB00B06N4S86 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.25 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/8/2013 07:31 | Are you happy thus far Piedro ? If the sale goes through will you start a new thread ? I will be supportive ... but only post say once/twice a month | buywell2 | |
05/8/2013 17:32 | Vindon Staff and Directors pose with 'Marilyn Monroe' at the Vindon California Grand Opening Event | piedro | |
23/7/2013 12:14 | VDN California website now available | piedro | |
17/7/2013 12:01 | You could do worse .... but check out Cyprotex (CRX) while you are at it | buywell2 | |
16/7/2013 21:06 | Or should we simply reinvest the cash in SBS? | eburne1960 | |
16/7/2013 18:40 | Very disappointing here, as a long term holder. However the outsourcing business is exceedingly tough at the moment, and taking a small loss for cash may not be so bad. Once the directors are committed it seems the die is cast. | bonzo | |
16/7/2013 13:26 | Let us see what transpires Piedro Perhaps you can take over and create one yourself | buywell2 | |
16/7/2013 13:22 | buywell2, Thank you. This certainly seems a good deal for Source BioScience but as a shareholder of VDN I feel disappointed - cash 13.70p and shut up !!! Not even a share offer. Re: the SBS bb, perhaps you could start a new one as that available is not very pleasant. | piedro | |
16/7/2013 09:55 | You have been ploughing a lone furrow for many years Piedro Your hard work has not gone unnoticed Welcome to the SBS fold My take is that with SBS using VDN storage facilities in the USA , and Ireland to sell SBS Life Sciences products , antibodies/clones/re www.sourcebioscience Also SBS have been expanding their DNA sequencing services at a pace , profits up circa 50% from this year on year .... they can now do the same from the two USA VDN bases and thus tap into the BIGGEST Pharma Biotech CRO area in the WORLD. Plus cross selling opportunities to each others Client Lists means the 'Collective' after assimilation should be more than the sum of each of the individuals within 12 months. Vindon will be the 5th SBS acquisition ..... Turnover for the first 6 months announced next month should be UP 30%. They are going places ..... check out the recent Institutional holdings taken in the company in the last 12 to 18 months. Some BIG names have bought in Major Shareholders holding over 3% ... Shares in issue :203.8m 2p Ords Name .................... TD Direct Investing (Europe) 21,000,000 ....10.0 Henderson Global Investors .. 12,095,215 ..... 5.9 Mr S Varkey .................. 3,522,581 ..... 1.73 Seren Capital Manag't ....... 10,675,000 ..... 6.6 SBS Directors/Snr Manag't ....14,222,897 ..... 7.38 Killik & Co LLP ............. 10,586,131 ..... 5.20 Blackrock Inv't Manag't ..... 10,715,000 ..... 5.26 Legal & Gen Assurance ....... 16,637,876 ..... 8.16 Barclays Bank Plc (Pvte Bing) 9,300,000 ...... 4.2 Standard Life Investments .... 9,500,000 ..... 4.66 Mr Yeung Yu Loong ........... 8,528,228 ...... 4.16 Swedbank Robur .............. 6,000,000 ...... 2.94 Talos Securities Ltd. ....... 5,900,000 ...... 2.9% 69% Per cent of shares held by top holders Source BioScience makes a strong start to the year 12 June 2013 | 14:47pm StockMarketWire.com - Source BioScience, which reported further growth and increased profitability in 2012, has made a good start to this year. Laurie Turnbull, chairman, told today's AGM: "Demand from the NHS for our diagnostic services continues to be strong and year to date revenue has increased by over 35% compared with the same period last year. "We remain one of only a small number of accredited laboratories in Europe with access to the technologies and expertise required to deliver complex gene-based diagnostic testing for cancer and other diseases, which affords us commercial advantage." Mr Turnbull also commented that the company enjoyed a leading position in the UK for the provision of DNA sequencing services and remain the only company offering a UK-based sequencing service. He added: "This part of our business will be boosted by the expansion of our service into Scotland, enabling us to offer our overnight service for DNA sequencing to the local research community. Hope this sits well Bro | buywell2 | |
15/7/2013 21:19 | eburne1960, We've been sold out by the board. I presume they'll be keeping their jobs. IMO - Indicates that the directors have been incapable of creating new partnerships or products - a takeover is their only option | piedro | |
15/7/2013 20:00 | Well well well, possible offer! What do you reckon Piedro? Personally, I'll make a small loss, but it's a decent premium and the shares have gone nowhere for a long time, so I think I'll take it and move on. | eburne1960 | |
11/7/2013 11:06 | Vindon at their Santa Fe Springs site are offering ... Thermal shock chambers for 3 stage thermal cycling No further information as yet. | piedro | |
05/7/2013 14:03 | ADVFN discriminatory campaign continues in the URL change 'hxxp' to 'http' | piedro | |
05/7/2013 13:58 | ... your invitation hxxp://www.vindoncal | piedro | |
04/7/2013 16:51 | Seemingly desperate for new products ... June 9, 2013 Integral Finance supported Vindon (Scientific) with work to strengthen it's new product pipeline. A sector specialist in the storage of pharmaceutical compounds under a range of tightly controlled environmental conditions, Vindon worked with Integral Finance to search for promising emergent technology, augment it's own life science expertise and help further it's growth plans. "This technology search was undertaken very professionally, and we now have several interesting new opportunities that we are exploring further." Patrick Jackson, Director Vindon Scientific Plc. hxxp://www.integralf | piedro | |
04/7/2013 12:42 | New Vindon storage suite opens at Santa Fe Springs SANTA FE SPRINGS, Calif. -- The latest controlled environment storage technology will soon be available for the Pharma and Biopharma industries when international storage specialists Vindon Scientific open their new facilities in California. The advanced storage suite will provide a unique service in California to major Pharmaceutical and Biopharma companies, CROs and CMOs that need GMP compliant controlled environment storage. .... .... Planning for the opening is well underway, with Marilyn Monroe look-alike Jodi Fleischer scheduled to perform the opening ceremony and cut the ribbon. The iconic 'Marilyn' will pose for photos with guests, so it really will be an occasion to remember. .... hxxp://www.fortmillt | piedro | |
25/6/2013 06:38 | Spotlight on Hackett Biologics 24th May 2013 .... Clinical trials using stem cell therapies for spinal cord injury, age-related macular degeneration, Crohn's disease, cardiovascular disease, critical limb ischemia, and multiple sclerosis have recently been publicised, but unless these stem cells can be stabilised the cell technologies can never achieve their full potential and become mainstream treatments. This means that companies will be seeking a storage and transport stabilisation product, as well as a product that can be administered into the body stabilisation all the way from manufacture to bedside - something that Hackett Biologics' technology can provide. .... hxxps://www.univerce | piedro | |
13/6/2013 14:48 | Work has continued on schedule and the controlled environment rooms are now installed and undergoing their internal fit out. Electrics are still being installed as well as the back up generator, essential to the secure continuous running of the storage suite. Before long the rooms will be undergo their validation in time for the suite to be operational well before the grand opening on 31st July 2013 | piedro | |
13/6/2013 14:37 | ... apologies for the state of the header - till ADVFN is back to normal. | piedro | |
13/6/2013 14:32 | Vindon's California storage facility Grand Opening Date Set » 31st July 2013 has been set as the date for the grand opening of Vindon's California Storage suite. It will be an interesting day, with the ribbon cutting performed by a special guest. Drinks and hors d'oeuvres will be available for guests and there will be an opportunity to meet Vindon's Director and Staff as well Vindon's partners who help make the facilities service offer complete. | piedro | |
12/6/2013 11:09 | Vindon advertising ... from hxxp://www.iptonline | piedro | |
03/6/2013 16:54 | Why? choose Vindon http://www.slideshar | piedro | |
09/5/2013 15:56 | Vindon Healthcare diversifies to support start-ups Last updated: 2nd Apr 2013 at 09:07am .... Ferguson told Insider the company had already started working with the University of Manchester and institutions in Leeds and Bristol. "We are looking at setting up an incubator unit in the UK and using our knowledge to cultivate and nurture fledgling businesses such as university spin outs," he said. "We recently appointed somebody internally to do that job specifically and have already got two or three interesting opportunities. "It's a simple fact that many biotech businesses come from universities and we feel we're in as good a position as anybody to invest in these sort of organisations, and for them to see us as a worthwhile investor. ... "But we're not just investing money, we're investing knowledge as well." | piedro | |
07/5/2013 11:10 | Article by Patrick Jackson Business Partnering The Way Forward for Cryogenics | piedro | |
03/5/2013 13:55 | pp-05 Vindon's California facility will provide the same ICH and custom storage services as the Atlanta facility, whilst also providing storage of controlled substances with our partner contract research organisations. Approximately 40 per cent of all public biotech companies in the nation are in California. The state is also home to more than 40 per cent of all employment in the sector and nearly half of all research and development spending in the sector occurs in California. | piedro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions